Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Inhibition of p38 MAP kinase in patients with ST-elevation myocardial infarction - findings from the LATITUDE-TIMI 60 trial.
Journal: American heart journal
Published: September 28, 2020
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.
Journal: JAMA
Published: April 05, 2016
Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial.
Journal: American heart journal
Published: December 31, 2014
Utility of concentration-effect modeling and simulation in a thorough QT study of losmapimod.
Journal: Journal of clinical pharmacology
Published: July 31, 2014
An effect of moderate hepatic impairment on the pharmacokinetics and safety of darapladib.
Journal: British journal of clinical pharmacology
Published: December 27, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026